SCHEMBL8346341

SCHEMBL8346341

Cc1c(/C(=C/C=O)c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 2/20 0.47
MAOA P21397 1/20 0.44
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
USP2 O75604 1/20 0.44
DAO P14920 1/20 0.43
DDO Q99489 1/20 0.43
AHR P35869 1/20 0.42
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 6/20 0.42
MEN1 O00255 5/20 0.42
LMNA P02545 3/20 0.42
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
MITF O75030 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346343 1.00 ALDH1A1 (0.47) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL8346132 1.00 ALDH1A1 (0.47) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL8346159 0.84 ALDH1A1 (0.51) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL8350787 0.80 ALDH1A1 (0.49) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL8343752 0.76 ALDH1A1 (0.56) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL2399274 0.76 ALDH1A1 (0.63) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL29897041 0.76 ALDH1A1 (0.63) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL29187517 0.72 MEN1 (0.49) ALDH1A1HSD17B10MAPTHPGDHTT
SCHEMBL2722021 0.72 ALDH1A1 (0.63) ALDH1A1HSD17B10MAOAMAPTHPGD
SCHEMBL24343238 0.71 ALDH1A1 (0.47) ALDH1A1HSD17B10MAOAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed